SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003720
Filing Date
2023-03-14
Accepted
2023-03-14 16:29:03
Documents
12
Period of Report
2023-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20230308x8k.htm   iXBRL 8-K 44154
  Complete submission text file 0001558370-23-003720.txt   165650

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20230308.xsd EX-101.SCH 3175
3 EX-101.LAB agrx-20230308_lab.xml EX-101.LAB 15926
4 EX-101.PRE agrx-20230308_pre.xml EX-101.PRE 10130
6 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20230308x8k_htm.xml XML 4810
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 23731433
SIC: 2834 Pharmaceutical Preparations